H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Brainsway to $12 from $13 and keeps a Buy rating on the shares. The analyst says the company’s leadership transition is likely to herald a focus on operating efficiency. The change in chief executive may signal greater focus on operating efficiency and expense control, particularly given management’s guidance of potential achievement of operational income break-even by the end of 2023, the analyst tells investors in a research note.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BWAY:
- Brainsway announces publication of post-marketing data analysis for Deep TMS
- BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS™ in Treating Depression and Anxious Depression
- BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights
- Brainsway reports Q4 EPS (12c) vs (4c) last year
- BrainsWay to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023